{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:06Z","timestamp":1761100866022},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1532\/ijh97.05157","type":"journal-article","created":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T20:31:27Z","timestamp":1150921887000},"page":"415-419","source":"Crossref","is-referenced-by-count":6,"title":["High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1007","volume":"83","author":[{"given":"Tatsuya","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Yokozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuharu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhito","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. <i>Bone Marrow Transplant<\/i>. 1994;<b>14<\/b>:495-504."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Busca A, Uderzo C. BMT: bone marrow transplant associated thrombotic microangiopathy. Hematology. 2000;<b>5<\/b>:53-67.","DOI":"10.1080\/10245332.2000.11746488"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Selby DM, Rudzki JR, Bayever ES, Chandra RS. Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation. Hum Pathol. 1999;<b>30<\/b>:734-740.","DOI":"10.1016\/S0046-8177(99)90132-6"},{"key":"E00004","unstructured":"Hirabayashi N. Thrombotic microangiopathy (TMA), 1: TMA in the target organs of graft-versus-host disease [in Japanese]. Rinsho Ketsueki. 2000;<b>41<\/b>:491-495."},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Nishida T, Hamaguchi M, Hirabayashi N, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant. 2004;<b>33<\/b>:1143-1150.","DOI":"10.1038\/sj.bmt.1704512"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.N Engl J Med. 1998;<b>339<\/b>:1578-1584.","DOI":"10.1056\/NEJM199811263392202"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med. 1998;<b>339<\/b>:1585-1594.","DOI":"10.1056\/NEJM199811263392203"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program). 2004;<b>407<\/b>:423.","DOI":"10.1182\/asheducation-2004.1.407"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. <i>Blood<\/i>. 1999;<b>93<\/b>:3798-3802.","DOI":"10.1182\/blood.V93.11.3798"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.Int J Hematol. 2002;<b>75<\/b>:25-34.","DOI":"10.1007\/BF02981975"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Kato S, Matsumoto M, Matsuyama T, Hiura H, Fujimura Y. Monoclonal antibodies to a VWF-A2 decapeptide with the C-terminal residue Tyr1605, generated by ADAMTS13 cleavage, develop a highly sensitive ELISA for its activity and characterize Upshaw-Schulman syndrome [abstract]. Blood. 2005;<b>106<\/b>:742a. Abstract 2643.","DOI":"10.1182\/blood.V106.11.2643.2643"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Kokame K, Matsumoto M, Fujimura Y, Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. <i>Blood<\/i>. 2004;<b>103<\/b>:607-612.","DOI":"10.1182\/blood-2003-08-2861"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Nelson KR, McQuillen MP. Neurologic complications of graftversus-host disease. Neurol Clin. 1988;<b>6<\/b>:389-403.","DOI":"10.1016\/S0733-8619(18)30877-6"},{"key":"E00014","unstructured":"Collins PW, Gutteridge CN, O'Driscoll A, et al. von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplant. 1992;<b>10<\/b>:499-506."},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Pham PT, Danovitch GM, Wilkinson AH, et al. Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient. Transplantation. 2002;<b>74<\/b>:1077-1080.","DOI":"10.1097\/00007890-200210270-00003"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Nakazawa Y, Hashikura Y, Urata K, et al. von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl. 2003;<b>9<\/b>:1328-1333.","DOI":"10.1016\/j.lts.2003.09.021"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Kierdorf H, Maurin N, Heintz B. Cyclosporine for thrombotic thrombocytopenic purpura.Ann Intern Med. 1993;<b>118<\/b>:987-988.","DOI":"10.7326\/0003-4819-118-12-199306150-00022"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Kokame K, Soejima K, et al. Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome. Blood. 2004;<b>103<\/b>:1305-1310.","DOI":"10.1182\/blood-2003-06-1796"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Motto DG, Chauhan AK, Zhu G, et al. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.J Clin Invest. 2005;<b>115<\/b>:2752-2761.","DOI":"10.1172\/JCI26007"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford). 2003;<b>42<\/b>:34-39.","DOI":"10.1093\/rheumatology\/keg025"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.05157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:48:27Z","timestamp":1586972907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.05157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["B564L01583236153"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.05157","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}